drugdeliverybusiness18h
FDA approves Abbott CGMs for use during medical imaging
Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.
drugdeliverybusiness20h
Beta Bionics launches iLet bionic pancreas with Abbott FreeStyle Libre 3 Plus
Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...
drugdeliverybusiness1d
Insulcloud wins FDA nod to bring smart insulin pen cap tech to U.S.
Insulcloud today announced its strategic expansion into the U.S. following FDA clearance for its Insulclock CAP smart device.
drugdeliverybusiness1d
Insulet fully launches Omnipod 5 app for iPhone in U.S.
Insulet (Nasdaq:PODD) today announced the full market release of the Omnipod 5 automated insulin delivery app for iPhone in the U.S.
drugdeliverybusiness2d
Tidepool, Abbott collab on data integration for FreeStyle Libre
Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...
drugdeliverybusiness2d
Dexcom submits 15-day CGM to FDA, beats Street in Q3
Dexcom announced today that, following the conclusion of the third quarter, it submitted its 15-day G7 CGM to the FDA.
drugdeliverybusiness5d
Senseonics announces $16M registered direct offering
Senseonics (NYSE:SENS) announced today that it entered into a definitive agreement to offer $16 million in common stock.